Preinduced reovirus-specific T-cell immunity enhances the anticancer efficacy of reovirus therapy

Preinduced reovirus-specific T-cell immunity enhances the anticancer efficacy of reovirus therapy

Background Many solid tumors do not respond to immunotherapy due to their immunologically cold tumor microenvironment (TME). We and others found that oncolytic viruses (OVs), including reovirus type 3 Dearing, can enhance the efficacy of immunotherapy by recruiting CD8+ T cells to the TME. A signifi...

Full description

Bibliographic Details
Main Authors: Rob C Hoeben, Sjoerd H van der Burg, Marjolein Sluijter, Thorbald van Hall, Joke M M Den Haan, Camilla Labrie, Christianne Groeneveldt, Priscilla Kinderman, Diana J M van den Wollenberg, Nadine van Montfoort, Lisa Griffioen, Jordi J C van Stigt Thans
Format: Article
Language:English
Published: BMJ Publishing Group 2022-07-01
Series:Journal for ImmunoTherapy of Cancer
Online Access:https://jitc.bmj.com/content/10/7/e004464.full

Internet

https://jitc.bmj.com/content/10/7/e004464.full

Similar Items